TACC3 deregulates the DNA damage response and confers sensitivity to radiation and PARP inhibition

Oncogene

Volumn 34, Issue 13, 2015, Pages 1667-1678

  Ha, G H ^a,b   Kim, J L ^a,b   Petersson, A ^a,b   Oh, S ^b   Denning, M F ^a,b   Patel, T ^b   Breuer, E K ^a,b  

^a LOYOLA UNIVERSITY HEALTH SYSTEM   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICROTUBULE ASSOCIATED PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; TACC3 PROTEIN, HUMAN;

ANTAGONISTS AND INHIBITORS; CHROMOSOME ABERRATION; DNA DAMAGE; DOUBLE STRANDED DNA BREAK; GENETICS; HUMAN; NEOPLASM; PHYSIOLOGY; RADIATION DOSE;

CHROMOSOME ABERRATIONS; DNA BREAKS, DOUBLE-STRANDED; DNA DAMAGE; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASMS; POLY(ADP-RIBOSE) POLYMERASES; RADIATION TOLERANCE;

EID: 84899044105     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2014.105     Document Type: Article

References (114)

1. Lauffart B, Sondarva GV, Gangisetty O, Cincotta M, Still IH. Interaction of TACC proteins with the FHL family: implications for ERK signaling. J Cell Commun Signal 2007; 1: 5-15.
2. Vettaikkorumakankauv A, Gangisetty O, Cincotta M, Hawthorne L, Cowell J, Still I. The TACC proteins are coregulators of the rentinoid × Receptor b. Cancer Therapy 2008; 6: 805-816.
3. Gangisetty O, Lauffart B, Sondarva GV, Chelsea DM, Still IH. The transforming acidic coiled coil proteins interact with nuclear histone acetyltransferases. Oncogene 2004; 23: 2559-2563.
4. Lauffart B, Gangisetty O, Still IH. Molecular cloning, genomic structure and interactions of the putative breast tumor suppressor TACC2. Genomics 2003; 81: 192-201.
5. Sadek CM, Pelto-Huikko M, Tujague M, Steffensen KR, Wennerholm M, Gustafsson JA. TACC3 expression is tightly regulated during early differentiation. Gene Expr Patterns 2003; 3: 203-211.
6. Ha GH, Kim JL, Breuer EK. Transforming acidic coiled-coil proteins (TACCs) in human cancer. Cancer Lett 2013; 336: 24-33.
7. Sadek CM, Jalaguier S, Feeney EP, Aitola M, Damdimopoulos AE, Pelto-Huikko M et al. Isolation and characterization of AINT: a novel ARNT interacting protein expressed during murine embryonic development. Mech Dev 2000; 97: 13-26.
8. Piekorz RP, Hoffmeyer A, Duntsch CD, McKay C, Nakajima H, Sexl V et al. The centrosomal protein TACC3 is essential for hematopoietic stem cell function and genetically interfaces with p53-regulated apoptosis. EMBO J 2002; 21: 653-664.
9. Garriga-Canut M, Orkin SH. Transforming acidic coiled-coil protein 3 (TACC3) controls friend of GATA-1 (FOG-1) subcellular localization and regulates the association between GATA-1 and FOG-1 during hematopoiesis. J Biol Chem 2004; 279: 23597-23605.
10. Jung CK, Jung JH, Park GS, Lee A, Kang CS, Lee KY. Expression of transforming acidic coiled-coil containing protein 3 is a novel independent prognostic marker in non-small cell lung cancer. Pathol Int 2006; 56: 503-509.
11. Schuendeln MM, Piekorz RP, Wichmann C, Lee Y, McKinnon PJ, Boyd K et al. The centrosomal, putative tumor suppressor protein TACC2 is dispensable for normal development, and deficiency does not lead to cancer. Mol Cell Biol 2004; 24: 6403-6409.
12. McKeveney PJ, Hodges VM, Mullan RN, Maxwell P, Simpson D, Thompson A et al. Characterization and localization of expression of an erythropoietin-induced gene, ERIC-1/TACC3, identified in erythroid precursor cells. Br J Haematol 2001; 112: 1016-1024.
13. Kinoshita K, Noetzel TL, Pelletier L, Mechtler K, Drechsel DN, Schwager A et al. Aurora A phosphorylation of TACC3/maskin is required for centrosomedependent microtubule assembly in mitosis. J Cell Biol 2005; 170: 1047-1055.
14. Schneider L, Essmann F, Kletke A, Rio P, Hanenberg H, Wetzel W et al. The transforming acidic coiled coil 3 protein is essential for spindle-dependent chromosome alignment and mitotic survival. J Biol Chem 2007; 282: 29273-29283.
15. Albee AJ, Wiese C. Xenopus TACC3/maskin is not required for microtubule stability but is required for anchoring microtubules at the centrosome. Mol Biol Cell 2008; 19: 3347-3356.
16. Lauffart B, Gangisetty O, Still IH. Evolutionary conserved interaction of TACC2/TACC3 with BARD1 and BRCA1: potential implications for DNA damage response in breast and ovarian cancer. Cancer Ther 2007; 5: 409-416.
17. Lauffart B, Howell SJ, Tasch JE, Cowell JK, Still IH. Interaction of the transforming acidic coiled-coil 1 (TACC1) protein with ch-TOG and GAS41/NuBI1 suggests multiple TACC1-containing protein complexes in human cells. Biochem J 2002; 363: 195-200.
18. Stewart JP, Thompson A, Santra M, Barlogie B, Lappin TR, Shaughnessy J Jr. Correlation of TACC3, FGFR3, MMSET and p21 expression with the t(4;14)(p16.3; q32) in multiple myeloma. Br J Haematol 2004; 126: 72-76.
19. Lauffart B, Vaughan MM, Eddy R, Chervinsky D, DiCioccio RA, Black JD et al. Aberrations of TACC1 and TACC3 are associated with ovarian cancer. BMC Womens Health 2005; 5: 8.
20. Ma XJ, Salunga R, Tuggle JT, Gaudet J, Enright E, McQuary P et al. Gene expression profiles of human breast cancer progression. Proc Natl Acad Sci USA 2003; 100: 5974-5979.
21. Kiemeney LA, Sulem P, Besenbacher S, Vermeulen SH, Sigurdsson A, Thorleifsson G et al. A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer. Nat Genet 2010; 42: 415-419.
22. Singh D, Chan JM, Zoppoli P, Niola F, Sullivan R, Castano A et al. Transforming fusions of FGFR and TACC genes in human glioblastoma. Science 2012; 337: 1231-1235.
23. Rhodes DR, Kalyana-Sundaram S, Mahavisno V, Varambally R, Yu J, Briggs BB et al. Oncomine 3.0: genes, pathways, and networks in a collection of 18, 000 cancer gene expression profiles. Neoplasia 2007; 9: 166-180.
24. Zhai Y, Kuick R, Nan B, Ota I, Weiss SJ, Trimble CL et al. Gene expression analysis of preinvasive and invasive cervical squamous cell carcinomas identifies HOXC10 as a key mediator of invasion. Cancer Res 2007; 67: 10163-10172.
25. Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, Bell GW et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007; 449: 557-563.
26. Hou J, Aerts J, den Hamer B, van Ijcken W, den Bakker M, Riegman P et al. Gene expression-based classification of non-small cell lung carcinomas and survival prediction. PLoS One 2010; 5: e10312.
27. Sun L, Hui AM, Su Q, Vortmeyer A, Kotliarov Y, Pastorino S et al. Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. Cancer Cell 2006; 9: 287-300.
28. D'Errico M, de Rinaldis E, Blasi MF, Viti V, Falchetti M, Calcagnile A et al. Genomewide expression profile of sporadic gastric cancers with microsatellite instability. Eur J Cancer 2009; 45: 461-469.
29. Roessler S, Jia HL, Budhu A, Forgues M, Ye QH, Lee JS et al. A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients. Cancer Res 2010; 70: 10202-10212.
30. Hong Y, Downey T, Eu KW, Koh PK, Cheah PY. A 'metastasis-prone' signature for early-stage mismatch-repair proficient sporadic colorectal cancer patients and its implications for possible therapeutics. Clin Exp Metastasis 2010; 27: 83-90.
31. Bonome T, Levine DA, Shih J, Randonovich M, Pise-Masison CA, Bogomolniy F et al. A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer. Cancer Res 2008; 68: 5478-5486.
32. Sanchez-Carbayo M, Socci ND, Lozano J, Saint F, Cordon-Cardo C. Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays. J Clin Oncol 2006; 24: 778-789.
33. Talantov D, Mazumder A, Yu JX, Briggs T, Jiang Y, Backus J et al. Novel genes associated with malignant melanoma but not benign melanocytic lesions. Clin Cancer Res 2005; 11: 7234-7242.
34. Grutzmann R, Pilarsky C, Ammerpohl O, Luttges J, Bohme A, Sipos B et al. Gene expression profiling of microdissected pancreatic ductal carcinomas using high-density DNA microarrays. Neoplasia 2004; 6: 611-622.
35. Hu N, Clifford RJ, Yang HH, Wang C, Goldstein AM, Ding T et al. Genome wide analysis of DNA copy number neutral loss of heterozygosity (CNNLOH) and its relation to gene expression in esophageal squamous cell carcinoma. BMC Genomics 2010; 11: 576.
36. Ha GH, Park JS, Breuer EK. TACC3 promotes epithelial-mesenchymal transition (EMT) through the activation of PI3K/Akt and ERK signaling pathways. Cancer Lett 2013; 332: 63-73.
37. Ha GH, Kim JL, Breuer EK. TACC3 Is Essential for EGF-Mediated EMT in Cervical Cancer. PLoS One, 2013; 8: e70353.
38. Yim EK, Tong SY, Ho EM, Bae JH, Um SJ, Park JS. Anticancer effects on TACC3 by treatment of paclitaxel in HPV-18 positive cervical carcinoma cells. Oncol Rep 2009; 21: 549-557.
39. Still IH, Vettaikkorumakankauv AK, DiMatteo A, Liang P. Structure-function evolution of the transforming acidic coiled coil genes revealed by analysis of phylogenetically diverse organisms. BMC Evol Biol 2004; 4: 16.
40. Hurov KE, Cotta-Ramusino C, Elledge SJ. A genetic screen identifies the Triple T complex required for DNA damage signaling and ATM and ATR stability. Genes Dev 2010; 24: 1939-1950.
41. Antoni L, Sodha N, Collins I, Garrett MD. CHK2 kinase: cancer susceptibility and cancer therapy-two sides of the same coin? Nat Rev Cancer 2007; 7: 925-936.
42. Bartkova J, Horejsi Z, Koed K, Kramer A, Tort F, Zieger K et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 2005; 434: 864-870.
43. Harper JW, Elledge SJ. The DNA damage response: ten years after. Mol Cell 2007; 28: 739-745.
44. Mistrik M, Oplustilova L, Lukas J, Bartek J. Low-dose DNA damage and replication stress responses quantified by optimized automated single-cell image analysis. Cell Cycle 2009; 8: 2592-2599.
45. Beck H, Nahse V, Larsen MS, Groth P, Clancy T, Lees M et al. Regulators of cyclin-dependent kinases are crucial for maintaining genome integrity in S phase. J Cell Biol 2010; 188: 629-638.
46. Asaithamby A, Chen DJ. Cellular responses to DNA double-strand breaks after low-dose gamma-irradiation. Nucleic Acids Res 2009; 37: 3912-3923.
47. Fairbairn DW, Olive PL, O'Neill KL. The comet assay: a comprehensive review. Mutat Res 1995; 339: 37-59.
48. Shrivastav M, De Haro LP, Nickoloff JA. Regulation of DNA double-strand break repair pathway choice. Cell Res 2008; 18: 134-147.
49. Obe G, Johannes C, Schulte-Frohlinde D. DNA double-strand breaks induced by sparsely ionizing radiation and endonucleases as critical lesions for cell death, chromosomal aberrations, mutations and oncogenic transformation. Mutagenesis 1992; 7: 3-12.
50. Li W, Li F, Huang Q, Shen J, Wolf F, He Y et al. Quantitative, noninvasive imaging of radiation-induced DNA double-strand breaks in vivo. Cancer Res 2011; 71: 4130-4137.
51. Frankenberg D, Frankenberg-Schwager M, Blocher D, Harbich R. Evidence for DNA double-strand breaks as the critical lesions in yeast cells irradiated with sparsely or densely ionizing radiation under oxic or anoxic conditions. Radiat Res 1981; 88: 524-532.
52. Jeggo PA, Lobrich M. DNA double-strand breaks: their cellular and clinical impact? Oncogene 2007; 26: 7717-7719.
53. Shibata A, Conrad S, Birraux J, Geuting V, Barton O, Ismail A et al. Factors determining DNA double-strand break repair pathway choice in G2 phase. EMBO J 2011; 30: 1079-1092.
54. Aguilera A, Gomez-Gonzalez B. Genome instability: a mechanistic view of its causes and consequences. Nat Rev Genet 2008; 9: 204-217.
55. d'Adda di Fagagna F, Teo SH, Jackson SP. Functional links between telomeres and proteins of the DNA-damage response. Genes Dev 2004; 18: 1781-1799.
56. Paull TT, Rogakou EP, Yamazaki V, Kirchgessner CU, Gellert M, Bonner WM. A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr BIol 2000; 10: 886-895.
57. Pan MR, Peng G, Hung WC, Lin SY. Monoubiquitination of H2AX protein regulates DNA damage response signaling. J Biol Chem 2011; 286: 28599-28607.
58. Downs JA, Nussenzweig MC, Nussenzweig A. Chromatin dynamics and the preservation of genetic information. Nature 2007; 447: 951-958.
59. Burma S, Chen BP, Murphy M, Kurimasa A, Chen DJ. ATM phosphorylates histone H2AX in response to DNA double-strand breaks. J Biol Chem 2001; 276: 42462-42467.
60. Chanoux RA, Yin B, Urtishak KA, Asare A, Bassing CH, Brown EJ. ATR and H2AX cooperate in maintaining genome stability under replication stress. J Biol Chem 2009; 284: 5994-6003.
61. Wang H, Wang M, Wang H, Bocker W, Iliakis G. Complex H2AX phosphorylation patterns by multiple kinases including ATM and DNA-PK in human cells exposed to ionizing radiation and treated with kinase inhibitors. J Cell Physiol 2005; 202: 492-502.
62. Lowndes NF, Toh GW. DNA repair: the importance of phosphorylating histone H2AX. Curr Biol 2005; 15: R99-R102.
63. Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 1998; 273: 5858-5868.
64. Ismail IH, Andrin C, McDonald D, Hendzel MJ. BMI1-mediated histone ubiquitylation promotes DNA double-strand break repair. J Cell Biol 2010; 191: 45-60.
65. Stewart GS, Wang B, Bignell CR, Taylor AM, Elledge SJ. MDC1 is a mediator of the mammalian DNA damage checkpoint. Nature, 2003; 421: 961-966.
66. Ward IM, Minn K, Jorda KG, Chen J. Accumulation of checkpoint protein 53BP1 at DNA breaks involves its binding to phosphorylated histone H2AX. J Biol Chem 2003; 278: 19579-19582.
67. Kobayashi J, Tauchi H, Chen B, Burma S, Tashiro S, Matsuura S et al. Histone H2AX participates the DNA damage-induced ATM activation through interaction with NBS1. Biochem Biophys Res Commun 2009; 380: 752-757.
68. Carney JP, Maser RS, Olivares H, Davis EM, Le Beau M, Yates JR 3rd et al. The hMre11/hRad50 protein complex and Nijmegen breakage syndrome: linkage of double-strand break repair to the cellular DNA damage response. Cell 1998; 93: 477-486.
69. Goldberg M, Stucki M, Falck J, D'Amours D, Rahman D, Pappin D et al. MDC1 is required for the intra-S-phase DNA damage checkpoint. Nature 2003; 421: 952-956.
70. Zhong Q, Chen CF, Li S, Chen Y, Wang CC, Xiao J et al. Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response. Science 1999; 285: 747-750.
71. Rappold I, Iwabuchi K, Date T, Chen J. Tumor suppressor p53 binding protein 1 (53BP1) is involved in DNA damage-signaling pathways. J Cell Biol 2001; 153: 613-620.
72. van den Bosch M, Bree RT, Lowndes NF. The MRN complex: coordinating and mediating the response to broken chromosomes. EMBO Rep 2003; 4: 844-849.
73. Bakkenist CJ, Kastan MB. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 2003; 421: 499-506.
74. Dodson GE, Shi Y, Tibbetts RS. DNA replication defects, spontaneous DNA damage, and ATM-dependent checkpoint activation in replication protein A-deficient cells. J Biol Chem 2004; 279: 34010-34014.
75. McKinnon PJ. ATM and ataxia telangiectasia. EMBO Rep 2004; 5: 772-776.
76. Jackson SP. Sensing and repairing DNA double-strand breaks. Carcinogenesis 2002; 23: 687-696.
77. Wang H, Powell SN, Iliakis G, Wang Y. ATR affecting cell radiosensitivity is dependent on homologous recombination repair but independent of nonhomologous end joining. Cancer Res 2004; 64: 7139-7143.
78. Deckbar D, Birraux J, Krempler A, Tchouandong L, Beucher A, Walker S et al. Chromosome breakage after G2 checkpoint release. J Cell Biol 2007; 176: 749-755.
79. Riballo E, Kuhne M, Rief N, Doherty A, Smith GC, Recio MJ et al. A pathway of double-strand break rejoining dependent upon ATM, Artemis, and proteins locating to gamma-H2AX foci. Mol Cell 2004; 16: 715-724.
80. Beucher A, Birraux J, Tchouandong L, Barton O, Shibata A, Conrad S et al. ATM and Artemis promote homologous recombination of radiation-induced DNA double-strand breaks in G2. EMBO J 2009; 28: 3413-3427.
81. Kocher S, Rieckmann T, Rohaly G, Mansour WY, Dikomey E, Dornreiter I et al. Radiation-induced double-strand breaks require ATM but not Artemis for homologous recombination during S-phase. Nucleic Acids Res 2012; 40: 8336-8347.
82. Pierce AJ, Johnson RD, Thompson LH, Jasin M. XRCC3 promotes homologydirected repair of DNA damage in mammalian cells. Genes Dev 1999; 13: 2633-2638.
83. Peng G, Yim EK, Dai H, Jackson AP, Burgt I, Pan MR et al. BRIT1/MCPH1 links chromatin remodelling to DNA damage response. Nat Cell Biol 2009; 11: 865-872.
84. Wu J, Zhang X, Zhang L, Wu CY, Rezaeian AH, Chan CH et al. Skp2 E3 ligase integrates ATM activation and homologous recombination repair by ubiquitinating NBS1. Mol Cell 2012; 46: 351-361.
85. Nakanishi K, Yang YG, Pierce AJ, Taniguchi T, Digweed M, D'Andrea AD et al. Human Fanconi anemia monoubiquitination pathway promotes homologous DNA repair. Proc Natl Acad Sci USA 2005; 102: 1110-1115.
86. Bartek J, Lukas J. DNA damage checkpoints: from initiation to recovery or adaptation. Curr Opin Cell Biol 2007; 19: 238-245.
87. Fernet M, Megnin-Chanet F, Hall J, Favaudon V. Control of the G2/M checkpoints after exposure to low doses of ionising radiation: implications for hyper-radiosensitivity. DNA Repair (Amst) 2010; 9: 48-57.
88. Nakada S, Katsuki Y, Imoto I, Yokoyama T, Nagasawa M, Inazawa J et al. Early G2/M checkpoint failure as a molecular mechanism underlying etoposideinduced chromosomal aberrations. J Clin Invest 2006; 116: 80-89.
89. Xu B, Kim S, Kastan MB. Involvement of Brca1 in S-phase and G(2)-phase checkpoints after ionizing irradiation. Mol Cell Biol 2001; 21: 3445-3450.
90. Lin SY, Rai R, Li K, Xu ZX, Elledge SJ. BRIT1/MCPH1 is a DNA damage responsive protein that regulates the Brca1-Chk1 pathway, implicating checkpoint dysfunction in microcephaly. Proc Natl Acad Sci USA 2005; 102: 15105-15109.
91. Rai R, Dai H, Multani AS, Li K, Chin K, Gray J et al. BRIT1 regulates early DNA damage response, chromosomal integrity, and cancer. Cancer Cell 2006; 10: 145-157.
92. Wang RH, Sengupta K, Li C, Kim HS, Cao L, Xiao C et al. Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice. Cancer Cell 2008; 14: 312-323.
93. Deng CX. BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution. Nucleic Acids Res 2006; 34: 1416-1426.
94. Gyorffy B, Lanczky A, Eklund AC, Denkert C, Budczies J, Li Q et al. An online survival analysis tool to rapidly assess the effect of 22, 277 genes on breast cancer prognosis using microarray data of 1, 809 patients. Breast Cancer Res Treat 2010; 123: 725-731.
95. Lio YC, Schild D, Brenneman MA, Redpath JL, Chen DJ. Human Rad51C deficiency destabilizes XRCC3, impairs recombination, and radiosensitizes S/G2-phase cells. J Biol Chem 2004; 279: 42313-42320.
96. Ma W, Halweg CJ, Menendez D, Resnick MA. Differential effects of poly(ADPribose) polymerase inhibition on DNA break repair in human cells are revealed with Epstein-Barr virus. Proc Natl Acad Sci USA 2012; 109: 6590-6595.
97. Ashworth A. A synthetic lethal therapeutic approach: poly(ADP) ribose polymerase inhibitors for the treatment of cancers deficient in DNA double-strand break repair. J Clin Oncol 2008; 26: 3785-3790.
98. Sourisseau T, Maniotis D, McCarthy A, Tang C, Lord CJ, Ashworth A et al. Aurora-A expressing tumour cells are deficient for homology-directed DNA double strand-break repair and sensitive to PARP inhibition. EMBO Mol Med 2010; 2: 130-142.
99. Partch CL, Gardner KH. Coactivators necessary for transcriptional output of the hypoxia inducible factor, HIF, are directly recruited by ARNT PAS-B. Proc Natl Acad Sci USA 2011; 108: 7739-7744.
100. Bargo S, Raafat A, McCurdy D, Amirjazil I, Shu Y, Traicoff J et al. Transforming acidic coiled-coil protein-3 (Tacc3) acts as a negative regulator of Notch signaling through binding to CDC10/Ankyrin repeats. Biochem Biophys Res Commun 2010; 400: 606-612.
101. Berkovich E, Ginsberg D. ATM is a target for positive regulation by E2F-1. Oncogene 2003; 22: 161-167.
102. Shanware NP, Zhan L, Hutchinson JA, Kim SH, Williams LM, Tibbetts RS. Conserved and distinct modes of CREB/ATF transcription factor regulation by PP2A/B56gamma and genotoxic stress. PLoS One 2010; 5: e12173.
103. Dell H, Hadzopoulou-Cladaras M. CREB-binding protein is a transcriptional coactivator for hepatocyte nuclear factor-4 and enhances apolipoprotein gene expression. J Biol Chem 1999; 274: 9013-9021.
104. Stroup D, Chiang JY. HNF4 and COUP-TFII interact to modulate transcription of the cholesterol 7alpha-hydroxylase gene (CYP7A1). J Lipid Res 2000; 41: 1-11.
105. Goodarzi AA, Noon AT, Deckbar D, Ziv Y, Shiloh Y, Lobrich M et al. ATM signaling facilitates repair of DNA double-strand breaks associated with heterochromatin. Mol Cell 2008; 31: 167-177.
106. Ziv Y, Bielopolski D, Galanty Y, Lukas C, Taya Y, Schultz DC et al. Chromatin relaxation in response to DNA double-strand breaks is modulated by a novel ATM-and KAP-1 dependent pathway. Nat Cell Biol 2006; 8: 870-876.
107. Bignold LP, Coghlan BL, Jersmann HP. Cancer morphology, carcinogenesis and genetic instability: a background. EXS 2006; 96: 1-24.
108. Mostoslavsky R, Chua KF, Lombard DB, Pang WW, Fischer MR, Gellon L et al. Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell 2006; 124: 315-329.
109. Bugler B, Schmitt E, Aressy B, Ducommun B. Unscheduled expression of CDC25B in S-phase leads to replicative stress and DNA damage. Mol Cancer 2010; 9: 29.
110. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001; 25: 402-408.
111. Ulisse S, Baldini E, Toller M, Delcros JG, Gueho A, Curcio F et al. Transforming acidic coiled-coil 3 and Aurora-A interact in human thyrocytes and their expression is deregulated in thyroid cancer tissues. Endocr Relat Cancer 2007; 14: 827-837.
112. Craig AL, Holcakova J, Finlan LE, Nekulova M, Hrstka R, Gueven N et al. DeltaNp63 transcriptionally regulates ATM to control p53 Serine-15 phosphorylation. Mol Cancer 2010; 9: 195.
113. Morton JP, Timpson P, Karim SA, Ridgway RA, Athineos D, Doyle B et al. Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer. Proc Natl Acad Sci USA 2010; 107: 246-251.
114. Yochum GS, Rajaraman V, Cleland R, McWeeney S. Localization of TFIIB binding regions using serial analysis of chromatin occupancy. BMC Mol Biol 2007; 8: 102.